Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by labumbaon Apr 28, 2009 11:51am
271 Views
Post# 15949764

RE: RESULTS IN CONTEXT

RE: RESULTS IN CONTEXTI quite agree with your good explanation

One more reminder....no patients would like to be on a drug either Cyclo or methotrexate over a year for psorasis indication , same as Voclo in   the futre.  patients have to go back to conventional treatments after the disease is reduced....my point is no patient would like to go back to the conventional treatment with some safety issues derived from the Cyclo
Bullboard Posts